Drugs

Photo from Vincent Rajkumar/X

Mar 30, 2024, 21:20

Vincent Rajkumar: 2 years later, over 2000 drugs – at low prices

Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared a post by Eric Feigl-Ding, Faculty, Chair of Public Health, Chief of COVID Task Force at New England Complex Systems Institute on X, adding:

“2 years later, it is >2000 drugs now— at low prices. The price differences can be dramatic.

Price difference Mark Cuban Cost Plus Drug Company vs Pharmacies.
Same drug. Same dose.

Vincent Rajkumar: 2 years later, over 2000 drugs - at low prices

Based on CostPlus and GoodRx search today for generic Evrolimus. Brand name cost is another story. Sad thing is patients who are the people paying don’t know that the same medicine can be so different in price.”

Quoting Eric Feigl-Ding’s post from 2022:

“REVOLUTIONARY—I cannot stress how epic Mark Cuban Cost Plus Drug Company is—there are now >100 generic medicines sold for often ~90% off list price (sometimes 140x lower) because Mark Cuban’s company has cut out profiteering big pharma and pharmacy middlemen. Generics sold at cost +15%. HUGE!”

Source: Vincent Rajkumar/X and Eric Feigl-Ding/X

cancer CostPlus Drugs Eric Feigl-Ding Evrolimus GoodRx Mark Cuban Mark Cuban Cost Plus Drug Company medicines OncoDaily Oncology patients Pharmacies pharmacy Vincent Rajkumar

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage